Evidence map›Paper›PMID 33789952›Full record

ArticleClinical medicine & research2021

Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC).

Adedayo A Onitilo, Trista J Stankowski-Drengler, Oyewale Shiyanbola, Jessica Engel, Sabo Tanimu, Seth O Fagbemi, Ya-Huei Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical medicine & research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Adedayo A OnitiloDepartment of Hematology/Oncology, Marshfield Clinic-Weston Center, Weston, Wisconsin onitilo.adedayo@marshfieldclinic.org.
Trista J Stankowski-DrenglerWisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Oyewale ShiyanbolaDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Jessica EngelDepartment of Hematology/Oncology, Marshfield Clinic-Weston Center, Weston, Wisconsin.
Sabo TanimuDepartment of Gastroenterology, Marshfield Clinic-Weston Center, Weston, Wisconsin.
Seth O FagbemiDepartment of Hematology/Oncology, Marshfield Clinic-Weston Center, Weston, Wisconsin.
Ya-Huei LiCancer Care and Research Center, Marshfield Clinic Research Institute, Marshfield, Wisconsin.
Marshfield Clinic Weston Center · USUniversity of Wisconsin–Madison · USMarshfield Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Esophageal NeoplasmsStomach NeoplasmsAgedAntineoplastic Combined Chemotherapy ProtocolsCisplatinDocetaxelFluorouracilHumansMaleMiddle AgedNeoadjuvant TherapyRetrospective StudiesTaxoidsCisplatinDocetaxelFluorouracilTaxoidsCommunityDisease-free survivalHematologic toxicitiesModified docetaxel, cisplatin, and fluorouracilNon-metastatic esophageal cancerOverall survival

Identifiers

PMID33789952
PMCPMC8231693
OpenAlexW3150933284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.